Authors:
A. Azeem Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by A. Azeem in
Current site
Google Scholar
PubMed
Close
,
M. Rizwan Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by M. Rizwan in
Current site
Google Scholar
PubMed
Close
,
F. J. Ahmad Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by F. J. Ahmad in
Current site
Google Scholar
PubMed
Close
,
Z. Iqbal Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by Z. Iqbal in
Current site
Google Scholar
PubMed
Close
,
R. K. Khar Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by R. K. Khar in
Current site
Google Scholar
PubMed
Close
,
M. Aqil Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by M. Aqil in
Current site
Google Scholar
PubMed
Close
, and
S. Talegaonkar Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, India

Search for other papers by S. Talegaonkar in
Current site
Google Scholar
PubMed
Close
Full access

Summary

An accurate, sensitive, precise, rapid and isocratic reversed-phase HPLC (RPHPLC) method for analysis of buspirone in the bulk drug and in solid dosage formulations has been developed and validated. The best separation was achieved on a 250 mm × 4.6 mm i.d., 5-μm particle, RP C18 column with 70:30 (υ/υ) methanol-0.01 m sodium dihydrogen phosphate buffer (pH 3.5) as mobile phase at a flow rate of 0.8 mL min−1. UV detection was at 244 nm. Response was a linear function of concentration over the range 0.05–20 μg mL−1 (r = 0.9998) and the limits of detection and quantitation were 3.7 and 11.3 ng mL−1, respectively. The method was validated in accordance with ICH guidelines. The drug was subjected to oxidative, hydrolytic, photolytic, and thermal stress. Degradation products produced as a result of this stress did not interfere with detection of buspirone and the assay can thus be regarded as stability-indicating. The method was used for quantification of buspirone in commercial buspirone tablets and to check content uniformity. The excipients present in the formulation did not interfere with the assay. The method is suitable for application in quality-control laboratories, because it is simple and rapid with good accuracy and precision.

  • [1]. A.S. Eison D.L. Temple 1986 Am. J. Med. 80 1.

  • [2]. K.L. Goa A. Ward 1986 Drugs 32 114.

  • [3]. H. Goldberg 1994 Pharmacotherapy 4 315.

  • [4]. R. Krysiak E. Obuchowicz Z.S. Herman 1986 Neur. Res. 51 924.

  • [5]. Z. Chilmonckyk H. Ksycinska J. Cybulski A. Wozniakowska-Szelejewska 1986 Die Pharm. 51 924.

  • [6]. A. Gobert A. Newman-Tancredi J.M. Rivet V. Audinot M.J. Millan 1997 Eur. Neuropyschopharmacol. 7 S149.

  • [7]. S.M. Fouroton A. Zarghi A.R. Shafaati A. Khoddam 2004 Farmaco 59 739.

  • [8]. X. Aparicio A. Campos J. Gras E. Fernandez E. Gelpi 1988 J. Pharm. Biomed. Anal. 6 945.

  • [9]. P. Betto A. Meneguz G. Ricciarello E. Fernandez C. Pichini 1992 J. Chromatogr. 575 117.

  • [10]. M. Franklin 1990 J. Chromatogr. 526 590.

  • [11]. J. Odontiadis M. Franklin 1996 J. Pharm. Biomed. Anal. 14 347.

  • [12]. W.M. Chew M.-J. Xu C.A. Cordova H.-H. Sherrychow 2006 J. Chromatogr. B 844 25.

  • [13]. S.-H. Cho H.-W. Lee H.-T. Im W.-S. Park Y.-W. Choi J.-H. Rew K.-T. Lee 2006 Rapid Commun. Mass Spectrom. 20 1293.

  • [14]. E. Nagele A.S. Fandino 2007 J. Chromatogr. A 1156 196.

  • [15]. J.W. Hager J.C. YvesLeBlanc 2003 J. Chromatogr. A 1020 3.

  • [16]. F. Kristjannson 1991 J. Chromatogr. 566 250.

  • [17]. T.H. Tsai C.F. Chen 1997 J. Chromatogr. A 762 269.

  • [18]. E.H. Kerns R.A. Routick K.J. Volk M.S. Lee 1997 J. Chromatogr. B 698 133.

  • [19]. C.A. Goldthwaite Jr F.-Y. Hsieh S.W. Womble B.J. Noves I.A. Blair 1996 Anal. Chem. 68 2996.

  • [20]. M.G. Quaglia A. Farina E. Bossu C.D. Aquila 1995 J. Pharm. Biomed. Anal. 13 505.

  • [21]. S.M. Sabry M.H. Barary M.H. Abdel Hay T.S. Belal 2004 J. Pharm. Biomed. Anal. 34 509.

  • [22]. A. Khedr A. Sekr 1999 J. Chromatogr. Sci. 37 462.

  • [23]. M. Zaxariou I. Panderi 2004 J. Pharm. Biomed. Anal. 35 41.

  • [24]. Z. Plotkowiak J. Cybulski M. Popielarz-Brzezinska A. Grzeszkiewicz I. Centrowska A. Kalska-Kowalska 1996 Chem. Anal. 41 983.

  • [25]. N. Adel-Ghani , Y. Issa, A. Shoukry, and H. Ahmed, Ann. Chim., 97 (2007).

  • [26]. J.A. Squella Y. Borges L. Bobadilla L.J. Nunez-Vergara 1990 Electroanal. J. 4 333.

  • [27]. W.M.A. Niessen J. Lin G.C. Bondoux 2002 J. Chromatogr. A 970 131.

  • [28]. R.T. Sane N.L. Chonken S.R. Surve M.G. Gangrade V.V. Bapat 1993 Indian Drugs 30 235.

  • [29]. V.C. Jacob S.N. Murthy J. Saravanan J. Ravishankar 1997 Indian Drugs 34 24.

  • [30]. International Conference on Harmonization (ICH), Validation of Analytical Procedures: Text and Methodology Q2 (R1), November 2005.

    • Search Google Scholar
    • Export Citation
  • [31]. S.C. Chow and J. Shao, Statistics in Drug Research: Methodologies and Recent Developments, Marcel Dekker, 2002, pp. 3152.

  • [32]. M. Zeaiter J.M. Roger V.B. Maurel D.N. Rutledge 2004 Trends Anal. Chem. 23 157.

  • [33]. M. Mulholland 1988 Trends Anal. Chem. 7 383.

  • [34]. ICH 2000 Stability Testing of New Drug Substances and Products (Q1AR). International Conference on Harmonisation IFPMA Geneva.

  • [35]. ICH 1999 Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. International Conference on Harmonisation IFPMA Geneva.

    • Search Google Scholar
    • Export Citation
  • [36]. International Conference on Harmonization 2003 Guidance for Industry, Q1A (R2): Stability Testing of New Drug Substances and Products IFPMA Geneva.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Senior editors

Editor(s)-in-Chief: Sajewicz, Mieczyslaw, University of Silesia, Katowice, Poland

Editors(s)

  • Danica Agbaba, University of Belgrade, Belgrade, Serbia (1953-2024)
  • Łukasz Komsta, Medical University of Lublin, Lublin, Poland
  • Ivana Stanimirova-Daszykowska, University of Silesia, Katowice, Poland
  • Monika Waksmundzka-Hajnos, Medical University of Lublin, Lublin, Poland

Editorial Board

  • Ravi Bhushan, The Indian Institute of Technology, Roorkee, India
  • Jacek Bojarski, Jagiellonian University, Kraków, Poland
  • Bezhan Chankvetadze, State University of Tbilisi, Tbilisi, Georgia
  • Michał Daszykowski, University of Silesia, Katowice, Poland
  • Tadeusz H. Dzido, Medical University of Lublin, Lublin, Poland
  • Attila Felinger, University of Pécs, Pécs, Hungary
  • Kazimierz Glowniak, Medical University of Lublin, Lublin, Poland
  • Bronisław Glód, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland
  • Anna Gumieniczek, Medical University of Lublin, Lublin, Poland
  • Urszula Hubicka, Jagiellonian University, Kraków, Poland
  • Krzysztof Kaczmarski, Rzeszow University of Technology, Rzeszów, Poland
  • Huba Kalász, Semmelweis University, Budapest, Hungary
  • Katarina Karljiković Rajić, University of Belgrade, Belgrade, Serbia
  • Imre Klebovich, Semmelweis University, Budapest, Hungary
  • Angelika Koch, Private Pharmacy, Hamburg, Germany
  • Piotr Kus, Univerity of Silesia, Katowice, Poland
  • Debby Mangelings, Free University of Brussels, Brussels, Belgium
  • Emil Mincsovics, Corvinus University of Budapest, Budapest, Hungary
  • Ágnes M. Móricz, Centre for Agricultural Research, Budapest, Hungary
  • Gertrud Morlock, Giessen University, Giessen, Germany
  • Anna Petruczynik, Medical University of Lublin, Lublin, Poland
  • Robert Skibiński, Medical University of Lublin, Lublin, Poland
  • Bernd Spangenberg, Offenburg University of Applied Sciences, Germany
  • Tomasz Tuzimski, Medical University of Lublin, Lublin, Poland
  • Adam Voelkel, Poznań University of Technology, Poznań, Poland
  • Beata Walczak, University of Silesia, Katowice, Poland
  • Wiesław Wasiak, Adam Mickiewicz University, Poznań, Poland
  • Igor G. Zenkevich, St. Petersburg State University, St. Petersburg, Russian Federation

 

SAJEWICZ, MIECZYSLAW
E-mail:mieczyslaw.sajewicz@us.edu.pl

Indexing and Abstracting Services:

  • Science Citation Index
  • SCOPUS
  • DOAJ
  • Sci Search
  • Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences
  • GoogleScholar
  • Index Copernicus
  • CABI
  • CABELLS Journalytics

2024  
Scopus  
CiteScore  
CiteScore rank  
SNIP  
Scimago  
SJR index 0.285
SJR Q rank Q3

2023  
Web of Science  
Journal Impact Factor 1.7
Rank by Impact Factor Q3 (Chemistry, Analytical)
Journal Citation Indicator 0.43
Scopus  
CiteScore 4.0
CiteScore rank Q2 (General Chemistry)
SNIP 0.706
Scimago  
SJR index 0.344
SJR Q rank Q3

Acta Chromatographica
Publication Model Online only
Gold Open Access
Submission Fee none
Article Processing Charge 700 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Acta Chromatographica
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
4
Founder Institute of Chemistry, University of Silesia
Founder's
Address
PL-40-007 Katowice, Poland, Bankowa 12
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2083-5736 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Dec 2024 0 98 23
Jan 2025 0 35 22
Feb 2025 0 51 14
Mar 2025 0 54 24
Apr 2025 0 37 24
May 2025 0 12 4
Jun 2025 0 0 0